Vanderbilt University Medical Center: Liquid Biopsy Test May Detect Early-Stage and Low DNA-Shedding Cancers
June 01, 2023
June 01, 2023
NASHVILLE, Tennessee, June 1 (TNSres) -- Vanderbilt University Medical Center issued the following news on May 31, 2023:
A liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers, according to data from a retrospective study presented at the AACR Annual Meeting 2023, held recently in Orlando, Florida.
"Detection of cancer in early stages through screening programs has b . . .
A liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers, according to data from a retrospective study presented at the AACR Annual Meeting 2023, held recently in Orlando, Florida.
"Detection of cancer in early stages through screening programs has b . . .